Overview

Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic Therapy

Status:
Unknown status

Trial end date:
2011-05-01

Target enrollment:

Participant gender:

Summary

This is a prospective, comparative control analysis. The investigators want to evaluate the aqueous humor levels of vascular endothelial growth factor in polypoidal choroidal vasculopathy and the effect of photodynamic therapy and combination treatment of photodynamic therapy and Lucentis (Ranibizumab)on the level of vascular endothelial growth factor.

Phase:

N/A

Details

Lead Sponsor:

Seoul St. Mary's Hospital

Treatments:

Ranibizumab
Verteporfin